Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anjali Mishra"'
Publikováno v:
Haematologica
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II study evaluated efficacy
Autor:
Anjali Mishra, Jordan Noble
Publikováno v:
Current Hematologic Malignancy Reports. 14:119-126
Animal models have played an indispensable role in interpreting cancer gene functions, pathogenesis of disease, and in the development of innovative therapeutic approaches targeting aberrant biological pathways in human cancers. These models have gui
Autor:
Rebecca Kohnken, Anjali Mishra
Publikováno v:
Journal of Investigative Dermatology. 139:528-534
MicroRNAs (miRs) are small, noncoding RNAs with numerous cellular functions. With advancing knowledge of the many functions of miRs in cancer pathogenesis, there is emerging interest in miRs as therapeutic targets in cancers. One disease that poses a
Autor:
William T. Johnson, Anjali Mishra
Publikováno v:
Blood. 134:1999-2000
Autor:
Jerald Z. Gong, William T. Johnson, Saritha Kartan, Bradley M. Haverkos, Anjali Mishra, Pierluigi Porcu, Alejandro A. Gru, Adetokunbo Folashade Oluwasanjo, Onder Alpdogan
Publikováno v:
Cancer Treatment and Research ISBN: 9783319997155
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a World Health Organization (WHO)-defined diagnostic category within the highly heterogeneous group of mature post-thymic T-cell neoplasms. It is the most common subtype of mature post
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ac11ff9e5d48861520f12f82ccea2c9
https://doi.org/10.1007/978-3-319-99716-2_4
https://doi.org/10.1007/978-3-319-99716-2_4
Autor:
Anjali Mishra, Jing Wen, Ashleigh Keiter, Kathleen McConnell, Luxi Chen, Leah Grinshpun, Betina McNeil, Basem M. William, Pierluigi Porcu, Rebecca Kohnken
Publikováno v:
The Journal of investigative dermatology. 139(9)
Cutaneous T-cell lymphomas (CTCLs) are a family of primary extranodal lymphomas of mature CD4+, skin-homing or skin-resident T cells. In a significant fraction of patients with CTCL, the neoplastic CD4+ lymphocytes acquire extracutaneous tropism, and
Autor:
Susan Hwang, Pierluigi Porcu, Nathan Denlinger, Bethany L. Mundy-Bosse, Michael A. Caligiuri, Li Chen, Aharon G. Freud, Youssef Youssef, Basem M. William, Dean A. Lee, Rebecca Kohnken, Nitin Chakravarti, Hsiaoyin Charlene Mao, Eric McLaughlin, Gerard Lozanski, David Kline, Anjali Mishra
Publikováno v:
Blood advances. 2(15)
Cutaneous T-cell lymphoma (CTCL) is a type of non-Hodgkin lymphoma characterized by the expansion of malignant CD4+ T cells in the skin. There are two main subtypes of CTCL: an indolent form termed mycosis fungoides (MF), which is largely limited to
Publikováno v:
Frontiers in Oncology
Murine models have been adopted as a significant and powerful tool in the study of cancer. The applications of murine models of cancer are numerous: mechanism discovery, oncogenesis, molecular genetics, microenvironment, metastasis, and therapeutic e
Sezary syndrome (SS) is a rare subtype of cutaneous T-cell lymphoma (CTCL) that is characterized by aggressive spread of neoplastic CD4+ T-cells from the skin into the bloodstream with metastasis to visceral organs. The deoxynucleoside triphosphohydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f346688d7e816970c87a9462a3e541d5
https://europepmc.org/articles/PMC5195900/
https://europepmc.org/articles/PMC5195900/
Autor:
Yue-Zhong Wu, Michael A. Caligiuri, Aharon G. Freud, Jonathan E. Brammer, Yaso Natkunam, Pierluigi Porcu, Anjali Mishra, Kathleen McConnell, Bethany L. Mundy-Bosse, Christopher C. Oakes, Robert A. Baiocchi, Christoph Weigel
Publikováno v:
Cancer Research. 79:LB-102
Extranodal natural killer/T cell lymphoma (ENKTL) is a rare aggressive form of non-Hodgkin lymphoma that is uniformly EBV-positive. Despite the implementation of combinatorial chemotherapies, almost all patients with advanced ENKTL die of their disea